用a1D受体高表达细胞膜色谱研究9种配体的生物亲和作用

为了增加细胞膜色谱法的选择性和特异性,用受体高表达细胞膜色谱法研究9种a1-肾上腺素受体配体与a1D-肾上腺素受体亚型(a1D-AR)的生物亲和作用.培养稳定表达a1D-AR的HEK293细胞株,制备细胞膜固定相,应用受体高表达细胞膜色谱法研究不同配体与a1D-AR的结合情况.结果表明:9种不同的a1-肾上腺素受体配体与大鼠a1D-AR的亲和顺序为:哌唑嗪,BMY7378,酚妥拉明,羟甲唑啉,5-甲基乌拉地尔,去甲肾上腺素,苯肾上腺素,甲氧明,RS-17053.受体高表达细胞膜色谱法是一种特异、可靠的生物亲和色谱方法,可用于a1D-AR亚型选择性药物的高效筛选.     

用α1D受体高表达细胞膜色谱研究9种配体的生物亲和作用

为了增加细胞膜色谱法的选择性和特异性, 用受体高表达细胞膜色谱法研究9种α₁-肾上腺素受体配体与α_1D-肾上腺素受体亚型(α_1D-AR)的生物亲和作用. 培养稳定表达α_1D-AR的HEK293细胞株, 制备细胞膜固定相, 应用受体高表达细胞膜色谱法研究不同配体与α_1D-AR的结合情况. 结果表明: 9种不同的α₁-肾上腺素受体配体与大鼠α_1D-AR的亲和顺序为: 哌唑嗪, BMY7378, 酚妥拉明, 羟甲唑啉, 5-甲基乌拉地尔, 去甲肾上腺素, 苯肾上腺素, 甲氧明, RS-17053. 受体高表达细胞膜色谱法是一种特异、可靠的生物亲和色谱方法, 可用于α_1D-AR亚型选择性药物的高效筛选.     

蛋白质多肽激素生物发光配基-受体结合测定新方法

蛋白质多肽激素是一大类内源信号分子,通过激活靶细胞膜上特定受体发挥重要调控功能。配基-受体结合测定是研究蛋白质多肽激素与受体相互作用的重要实验方法,但传统方法要使用放射性同位素(如碘-125),限制了该方法的广泛使用。我们在近期工作中利用超灵敏的Nano Luc荧光素酶建立了"生物发光配基-受体结合测定新方法"用于研究蛋白质多肽激素与受体的相互作用。该方法具有灵敏度高、重复性好、安全无害、操作简便等的优点,有望广泛用于蛋白质多肽激素与受体相互作用研究。     

分子模拟在多黏菌素药理机制研究中的应用

多黏菌素是一种膜靶向的脂肽类抗生素，是临床上治疗革兰氏阴性多重耐药菌感染的最后一道防线。通过与脂多糖相互作用，多黏菌素破坏细菌外膜结构并导致细菌死亡。然而，受限于生物化学和结构生物学手段对细胞膜-药物相互作用的表征能力，目前对多黏菌素药理机制的认识还不充分，从而限制了新一代多黏菌素药物的设计和开发。为此，本文总结了近年来利用分子动力学方法对细胞膜系统与多黏菌素相互作用的研究进展，为深入理解多黏菌素药理机制与细胞膜系统的内在联系，加快新型抗生素药物研发提供新思路。     

肿瘤细胞死亡受体的调控

肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor related apoptosis inducing ligand,TRAIL)只有与细胞膜上死亡受体结合才能促使癌细胞凋亡,一旦细胞膜上的死亡受体发生缺失或失去活性,将使癌细胞对TRAIL极为耐受。近年来,对死亡受体的研究发现,死亡受体异常表达可能是死亡受体在细胞膜上发生功能性缺失的最主要原因。该文主要探究肿瘤细胞中死亡受体在转录调控、翻译后修饰、转运和内化过程中的异常情况,期望为今后研发克服TRAIL耐受的联合药物及癌症治疗提供参考。     

G蛋白偶联受体的双聚化及其对受体介导信号转导的影响

近年来发现一些G蛋白偶联受体（GPCR）能在细胞膜上形成同源或异源双聚体,并证实受体的双聚化为一些有重要生理功能的GPCR在细胞膜上的表达和信号转导的启动所必需,进一步研究表明,一些GPCR的双聚化不仅可以改变受体与配体结合的特异性和亲和力,而且影响GPCR介导的信号转导的调控,这些结果提示,GPCR之间以及GPCR与其它蛋白在细胞膜上的相互作用是调控GPCR转导信号的一个新途径。     

应用椭偏光学显微成像对IL-6与其受体的相互应用的初步观察

白细胞介素 6 (ＩＬ 6 )是一种具有复杂生物功能的细胞因子 ,可由多种淋巴类和非淋巴类细胞产生。它对机体多种组织及细胞均有不同程度的作用[1～ 3 ] 。近年来发现 ,临床上免疫异常性疾病 ,如发热、淋巴结肿大、血沉增快、急性期蛋白增高、高γ球蛋白血症、自身抗体阳性等症状都与ＩＬ 6的异常表达密切相关。ＩＬ 6的生物活性是通过细胞膜表面特异性受体介导的[4] 。研究ＩＬ 6与其受体的相互作用对于揭示某些疾病的发病机制 ,监测疾病进程以及指导临床治疗等均具有重要意义。用于研究ＩＬ 6与其受体相互作用的方法主要有ＩＬ 6依赖株细胞…     

大肠杆菌耐热肠毒素1型的结构与其受体的研究进展

对大肠杆菌耐热肠肠毒素１型（ＳＴ１）及其受体结构功能和它们相互作用机制的研究,不仅是研究类似ＳＴ１等小肽类毒素作用机制的基础,而且对于人们研究细胞膜上信使传递途径也是一种有效的手段。本文就近几年大肠杆菌ＳＴ１的分子结构,尤其是ＳＴ１分子内二硫链及其三维空间构型与功能关系的研究,ＳＴ１受体的性质,纯化以及ＳＴ１与受体相互作用机制研究等方面的进展作了介绍。     

生物功能化色谱技术研究胰岛素与其受体间的相互作用

生物功能化色谱技术是通过模拟细胞膜表面环境,在色谱系统内实现研究生物分子间相互作用过程的新技术。利用生物功能化色谱方法研究了胰岛素与其受体间的相互作用。将提取出的胰岛素受体混合物固定化在人工膜(Immobilized artificial membrane, IAM)的表面,并确定了固定化的最佳pH值为7.2,最佳离子强度为20 mmol,最佳有机溶剂浓度为2% (v/v)。通过区带洗脱法确定了胰岛素受体的存在及其与胰岛素间存在相互作用;通过前沿分析法确定了胰岛素受体与胰岛素间相互作用的结合常数大小约为0.701 nmol/L。     

CD147在调节性T细胞中作用的研究进展

CD147是一种免疫球蛋白超家族,它与肿瘤侵袭和转染,类风湿性关节炎,病毒入侵,淋巴细胞的迁移和活化,老年痴呆症,疟原虫入侵等病理过程密切先关,已成为癌症等疾病的新型药物靶标分子。作为一个单次跨膜蛋白,CD147的多功能性依赖于它的胞外结构域以及细胞膜和细胞外多种分子的相互作用。有研究发现CD147可作为细胞膜受体并且在上皮细胞,肿瘤细胞和免疫T细胞中均有表达。其可作为T细胞亲环素受体并具有趋化T细胞的功能。近几年研究发现,CD147在调节性T细胞高表达并且具有标志性意义。该文就以作为活性调节性T细胞标志的CD147的潜在作用进展综述如下。     

Chromatography studies on bio-affinity of nine ligands of a1-adrenoceptor to a1D subtypes overexpressed in cell membrane

Copyright by Science in China Press 2004 The a1-AR is present in many tissues including heart, blood vessels, liver, brain, kidney, prostate and spleen. In these tissues, the a1-AR mediates a variety of physiological effects such as neurotransmission, vasoconstriction, cardiacinotropy, chronotropy and glycogenolysis[1]. In 1986, Morrow and Greese pro-posed that a1-AR should be subclassified into two subtypes. Later this hypothesis was proved by Q.D Han in 1987. He not only verified a1-A…     

Chromatography studies on bioaffinity of nine ligands of α1 adrenoceptor to α1D subtypes overexpressed in cell membrane

To improve selectivity and specificity of cell membrane chromatography (CMC), the chromatography affinities of nine ligands of α₁-adrenergic receptor(AR)to α_1D-AR subtype were investigated. The human embryonic kidney (HEK) 293 cells expressed by cDNA of α_1D-AR subtypes were cultured and cell membrane stationary phase (CMSP) was prepared. Then the interactions between ligands and α_1D-AR in CMSP were investigated using CMC. The affinity rank order to α_1D-AR subtype obtained from CMC for the nine α₁-adrenoceceptor ligands is: prazosin, BMY7378, phentolamine, oxymetazoline, 5-methylurapidil, norepinephrine, phenylephrine, methoxamine, RS-17053. The affinity rank order is similar and correlates well with that obtained from others’ radioligand binding assays (RBA). CMSP prepared by transfected HEK293 cells with α_1D-adrenoceptor cDNA and CMC method could be used to evaluate affinities of drug-receptor and drug-receptor subtypes and to screen drugs selective to α_1D-AR.     

Chromatography studies on bio-affinity of nine ligands of α1-adrenoceptor to α1D subtypes overexpressed in cell membrane

To improve selectivity and specificity of cell membrane chromatography (CMC), the chromatography affinities of nine ligands of α₁-adrenergic receptor(AR)to α_1D-AR subtype were investigated. The human embryonic kidney (HEK) 293 cells expressed by cDNA of α_1D-AR subtypes were cultured and cell membrane stationary phase (CMSP) was prepared. Then the interactions between ligands and α_1D-AR in CMSP were investigated using CMC. The affinity rank order to α_1D-AR subtype obtained from CMC for the nine α₁-adrenoceceptor ligands is: prazosin, BMY7378, phentolamine, oxymetazoline, 5-methylurapidil, norepinephrine, phenyle-phrine, methoxamine, RS-17053. The affinity rank order is similar and correlates well with that obtained from others’ radioligand binding assays (RBA). CMSP prepared by transfected HEK293 cells with α_1D-adrenoceptor cDNA and CMC method could be used to evaluate affinities of drug-receptor and drug-receptor subtypes and to screen drugs selective to α_1D-AR.     

Threshold interaction energy of NRTI's (2'-deoxy 3'-substituted nucleosidic analogs of reverse transcriptase inhibitors) to undergo competitive inhibition

A quantum pharmacological study has been carried out on nucleosidic inhibitors for HIV-1RT where ab initio HF molecular orbital calculations in conjunction with other quantum mechanical techniques have been utilized in a systematic manner to understand the pharmacophoric features and evaluate specific drug-receptor interactions. The interaction energy between the drug and the closest asp 185 of the catalytic triad has been indicated to be crucial in determining the potency of the nucleosidic drug. This study also emphasizes on identifying important specific drug-receptor interactions and evaluating them at the microscopic level to understand the potency regulation as minor conformational changes may lead to significant difference in interaction energies. Although based on relatively few points our correlation of interaction energies with potency data indicates requirement of approximately 13 kcal/mol threshold interaction energy for the drug to undergo efficient competitive inhibition.     

(Extra)thermodynamics of the drug-receptor interaction.

A core concept in pharmacology is drug-receptor affinity, i.e., the tendency of a drug molecule to bind to one or more receptors due to the collective influence of multiple molecular forces. The estimation of affinity as a dissociation constant (reciprocal of the equilibrium constant) is extraordinarily valuable. However, elucidation of the nature of the underlying concept--i.e., what accounts for affinity--is not achievable using such a static measure. Observing how the system responds to a perturbation (e.g., to a change in temperature) reveals more fundamental information. The present review summarizes the general concepts of thermodynamic analysis applied to drug-receptor interactions and discusses 'extrathermodynamic' phenomena, such as enthalpy-entropy 'compensation'. Together, these concepts may provide insight into the nature of drug-receptor interactions, begin to elucidate the forces that underlie such interactions--and begin to define and refine more nebulous terms such as affinity.     

Thermodynamic analysis of the drug-receptor interaction

Thermodynamic analysis of pharmacologic data potentially offers an insight into the molecular events underlying drug-receptor interactions not obtainable by other techniques. Embodied in thermodynamics are the laws governing the interconvertibility of heat and work and, hence, it is a particularly apt framework for the analysis of the transduction of information from ligand to biological tissue during the initiation of a drug effect. Implicit in thermodynamic analysis of pharmacologic data is quantitative measurement of the driving forces involved in the drug-receptor interaction (in place of less precise terms such as "affinity"). In addition, the cautious interpretation of thermodynamic analysis can give clues to the underlying mechanisms of the drug-receptor interaction that is beyond the resolving power of other parameters, such as the dissociation constant. The present review is an attempt to identify representative reports that have overtly analyzed pharmacologic data with thermodynamic analysis, to summarize the findings within and across studies (particularly regarding enthalpy- versus entropy-driven binding of agonists and antagonists), to point out and address some apparent inconsistencies that can arise, and to consider the application of thermodynamic analysis to data obtained using isolated tissue preparations.     

Model-based relationship between physicochemical properties and inhibitory potency of alkylating 2-furylethylenes on yeast glycolysis

Inhibitory effects of 35 2-furylethylenes, non-specific alkylating agents, on glycolysis in a respiratory mutant of Saccharomyces cerevisiae were correlated with their 1-octanol/water partition coefficients and the rate constants for reaction with 2-mercaptoacetic acid using physiologically based models. The simplest model explaining the data satisfactorily consists of two-step drug-receptor interaction involving reversible formation of a structurally non-specific non-covalent complex stabilized later covalently. The concentration of the free drug in the receptor surroundings was related to its initial concentration in external medium via a simple form of a disposition function constructed on the basis of time hierarchy of passive membrane transport, non-covalent binding to cell constituents and metabolic inactivation of the drug.     

Targeting the human genome-microbiome axis for drug discovery: inspirations from global systems biology and traditional Chinese medicine

Most chronic diseases impairing current human public health involve not only the human genome but also gene-environment interactions, and in the latter case the gut microbiome is an important factor. This makes the classical single drug-receptor target drug discovery paradigm much less applicable. There is widespread and increasing international interest in understanding the properties of traditional Chinese medicines (TCMs) for their potential utilization as a source of new drugs for Western markets as emerging evidence indicates that most TCM drugs are actually targeting both the host and its symbiotic microbes. In this review, we explore the challenges of and opportunities for harmonizing Eastern-Western drug discovery paradigms by focusing on emergent functions at the whole body level of humans as superorganisms. This could lead to new drug candidate compounds for chronic diseases targeting receptors outside the currently accepted "druggable genome" and shed light on current high interest issues in Western medicine such as drug-drug and drug-diet-gut microbial interactions that will be crucial in the development and delivery of future therapeutic regimes optimized for the individual patient.     

Locust nymphal neurones in culture: a new technique for studying the physiology and pharmacology of insect central neurones

A new technique for studying the physiology and pharmacology of locust central neurones is described. Somata isolated from neurones in the meso and metathoracic ganglia of third instar locusts (Schistocerca gregaria) were maintained for up to 4 weeks in co-culture (monolayer) with embryonic locust neurones. Most of the cultured cells became multipolar but a few were monopolar like their in vivo counterparts. They had diameters of 40-80 microns and "clean" (glial free) surface membranes. Cells 6-14 days in vitro were depolarized by acetylcholine and usually hyperpolarized by gamma-aminobutyrate, taurine and glycine. L-Glutamate and L-aspartate were inactive but further pharmacological studies are required to confirm this. Cultured larval neurones should provide excellent opportunities to study the molecular basis for drug-receptor interactions and voltage-sensitive membrane channels using the patch clamp technique.     

The Dissociation Rate of Unlabelled Drugs from Receptor Sites: A Poorly Investigated,Yet Important Aspect in Receptor Research. Studies on the Serotonin-S2 Receptor

Abstract

The labelling by ³H-spiperone of serotonin-S₂ receptors in rat frontal cortex tissue adsorbed to glass fibre filters was investigated. For 12 unlabelled serotonin antagonists the dissociation time from serotonin-S₂ receptors was measured using rat frontal cortex tissue preparations adsorbed to glass fibre filters. The dissociation half-time varied from 4.8 min for pipamperone to 160 min for ritanserin. The drug-receptor dissociation time was not related to a particular class of chemical structure, or to the lipophilicity or the acid dissociation constant of the drugs. The essential requirement of experimental determination of the drug-receptor dissociation time for each drug individually is illustrated. The possible applications of the knowledge of the drug-receptor dissociation time in in vitro and in vivo receptor studies, in pharmacological and pharmaco-kinetic studies and in drug design and receptor modelling is discussed. For various serotonin-S₂ antagonists, the type of inhibition produced by the drug on ³H-ketanserin binding to serotonin-S₂ receptors was determined using suspensions of rat frontal cortical tissue. The observed patterns of inhibition were clearly related to the drug-receptor dissociation times: rapidly dissociating drugs produced competitive inhibition, drugs with dissociation half-times between 15-30 min produced mixed type inhibition, and the very slowly dissociating ritanserin produced non-competitive inhibition.